Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease.
Myrte K Neijenhuis, Tom J G Gevers, Marie C Hogan...
https://pubmed.ncbi.nlm.nih.gov/26970415/Actively Recruiting
Led by Portsmouth Hospitals NHS Trust · Updated on 2025-12-23
500
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are observing the natural course of polycystic liver disease PLD through a multicenter registry in the UK, which is part of a larger international study led by Radboud University Medical Center in the Netherlands. This registry aims to collect data on patient characteristics, risk factors, symptoms, quality of life, and treatment strategies for PLD. It includes patients with PLD, either isolated or associated with polycystic kidney disease PKD, characterized by having more than 10 liver cysts. This study does not involve experimental treatments but collects data prospectively and retrospectively from participants. A validated questionnaire specific to PLD PLD-Q is used to assess quality of life. The registry will follow participants for up to 10 years to monitor disease progression, risk factors, and the effectiveness of different therapies. Participants will provide data over the course of the study including completion of the PLD-Q questionnaire. Researchers will track outcomes such as the natural progression of PLD, quality of life changes, liver growth rate, and complications. The long-term follow-up of 10 years allows detailed understanding of the disease and its management. Results will be shared at national and international scientific meetings.
CONDITIONS
Polycystic Liver Disease Registry (UK)
R
Richard Aspinall, BSc, MBChB, PhD
B
Benjamin Giles, BSc, MBBS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Portsmouth Hospitals NHS Trust
Lead Sponsor
Radboud University Medical Center
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years
Participants are observed over time to collect data on the natural course of polycystic liver disease, including quality of life, risk factors, disease progression, and treatment outcomes.
Periodic visits as scheduled by the registry
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Myrte K Neijenhuis, Tom J G Gevers, Marie C Hogan...
https://pubmed.ncbi.nlm.nih.gov/26970415/Qi Qian, Airong Li, Bernard F King...
https://pubmed.ncbi.nlm.nih.gov/12500201/René M M van Aerts, Liyanne F M van de Laarschot, Jesus M Banales...
https://pubmed.ncbi.nlm.nih.gov/29175241/Portsmouth Hospitals NHS Trust
Lead Sponsor
Radboud University Medical Center
Collaborating Sponsor